(Nasdaq: XCUR) today announced that it has entered into a co-development agreement with Adbiotech Co., Ltd. (KOSDAQ: 179530), a Korea-based biotechnology company, to explore combination therapies ...

Exicure Inc. Annual stock financials by MarketWatch. View the latest XCUR financial statements, income statements and financial ratios.

Exicure, Inc. (NADAQ:XCUR) stock is trading higher on Monday after the company entered into debt-for-equity exchange agreements. What Happened: On Friday, Exicure filed a Form 8-K with the Securities ...

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...

We recently compiled a list of the 10 Micro-, Small-Cap Companies Lead Monday's Charge. In this article, we are going to take a look at where Exicure Inc. (NASDAQ:XCUR) stands against the other stocks ...

Systems Inc. HiTron, a 10% owner of $XCUR, bought 2,900,000 shares of the company on 12-26-2024 for an estimated $8,700,000. This trade was reported by Quiver ...

REDWOOD CITY, Calif., April 11, 2025--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc.